ICBI is a biotechnology company that develops BBB permeable technology solutions for brain diseases... Read more
ICBI is a biotechnology company that develops BBB permeable technology solutions for brain diseases... Read more
News
Sep 23, 2021
Markets Insider
ICBII: ICBII Announces Approval of Its 7th Patent on Blood-Brain Barrier Permeable Technology, Moving Closer to Clinical Trials on its drugs for Alzheimer's, Parkinson's, and Other Neuro-Degenerative Dis...
Apr 15, 2020
StreetInsider
Press Release: ICBII : ICBII Announces the Approval of its latest patent on Blood-Brain Barrier Permeable Technology accelerating the company's progress towards treating Neuro-Degenerative Alzheimer's and Parkinson's Diseas
Dec 05, 2017
Market Cheetah
Icbi: ICBII Announces the Filing of Orphan Drug Designation Application for the Use of α-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy
Jul 09, 2016
ICBII Vimeo Channel
ICBII posted a video "ICB International - Beating the Blood Brain Barrier" on VIMEO
Jun 08, 2016
ICBII Vimeo Channel
ICBII posted a video "ICBI "outSMARTing barriers" - Company Overview" on VIMEO
May 13, 2016
ICBII Vimeo Channel
ICBII posted a video "Validation of Clinical Potential of alpha-synuclein Smart Molecule" on VIMEO
May 13, 2016
ICBII Vimeo Channel
ICBII posted a video "ICB International - SMART Molecule Technology Platform" on VIMEO
Jun 10, 2015
ETELIGIS
Press Release: Icbi : ICB International, Inc. Launches Blood-Brain Barrier Crossing Smart Molecule Platform Technology and Engages Alan Morell, Creative Management Partners as Senior Advisor
ICBII Competitors
1
2
3
4
5
6
7
8
9
10